Patents by Inventor Sun Chul HUR

Sun Chul HUR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thienopyridine derivatives and pharmaceutical composition comprising same
    Patent number: 11447500
    Abstract: A thienopyridine derivative compound represented by Formula 1 or pharmaceutically acceptable salts thereof have an excellent inhibitory effect on protein kinase activity, and accordingly, pharmaceutical compositions containing the thienopyridine compound can be usefully used for the prevention or treatment of a disease associated with the activity of a protein kinase.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: September 20, 2022
    Assignee: WELLMARKER BIO CO., LTD.
    Inventors: Hyunho Lee, Chun-Ho Park, Sun Chul Hur, Jai-Hee Moon, Jae-Sik Shin, Seung-Woo Hong, Yoon-Sun Park, Joseph Kim, Sohee Lee, Hyojin Kim, Hyebin Park
  • THIENOPYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
    Publication number: 20220288043
    Abstract: A thienopyridine derivative compound of Formula 1 or pharmaceutically acceptable salts thereof have an excellent inhibitory effect on protein kinase activity, and accordingly, pharmaceutical compositions containing the thienopyridine compound can be usefully used for the prevention or treatment of a disease associated with the activity of a protein kinase. Therefore, a use of the compound or a pharmaceutically acceptable salt thereof in treating a disease associated with an activity of a protein kinase in a subject in need thereof is disclosed.
    Type: Application
    Filed: May 26, 2022
    Publication date: September 15, 2022
    Applicant: WELLMARKER BIO CO, LTD.
    Inventors: Hyunho LEE, Chun-Ho PARK, Sun Chul HUR, Jai-Hee MOON, Jae-Sik SHIN, Seung-Woo HONG, Yoon-Sun PARK, Joseph KIM, Sohee LEE, Hyojin KIM, Hyebin PARK
  • THIENOPYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
    Publication number: 20210317133
    Abstract: A thienopyridine derivative compound represented by Formula 1 or pharmaceutically acceptable salts thereof have an excellent inhibitory effect on protein kinase activity, and accordingly, pharmaceutical compositions containing the thienopyridine compound can be usefully used for the prevention or treatment of a disease associated with the activity of a protein kinase.
    Type: Application
    Filed: March 8, 2019
    Publication date: October 14, 2021
    Applicant: WELLMARKER BIO CO., LTD.
    Inventors: Hyunho LEE, Chun-Ho PARK, Sun Chul HUR, Jai-Hee MOON, Jae-Sik SHIN, Seung-Woo HONG, Yoon-Sun PARK, Joseph KIM, Sohee LEE, Hyojin KIM, Hyebin PARK